AU Patent

AU728701B2 — Compounds that inhibit the binding of Raf-1 or 14-3-3 proteins to the beta chain of IL-2 receptor, and pharmaceutical compositions containing same

Assigned to Applied Research Systems ARS Holding NV · Expires 2001-01-18 · 25y expired

What this patent protects

Patent listed against Mektovi.

Drugs covered by this patent

Patent Metadata

Patent number
AU728701B2
Jurisdiction
AU
Classification
—
Expires
2001-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Applied Research Systems ARS Holding NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.